We have performed microperfusion studies on distal tubules of normal and alkalotic rats in an attempt to demonstrate in vivo bicarbonate secretion. All perfusion solutions were free of phosphate and other nonbicarbonate buffers. In both normal and alkalotic rats, distal perfusions elicited significant tCO2 entry only at high flow (24 nl/min). Even when perfusate tCO2 concentration closely matched plasma tCO2 concentration (30 mM tCO2), significant tCO2 entry again occurred at high flow. This was associated with a rise of the perfusate tCO2 concentration, which indicated net entry of tCO2 against A concentration gradient. In this "symmetrical" perfusion situation, acetazolamide blockade prevented tCO2 entry. Accordingly: (a) distal tubule tCO2 entry is demonstrable in both alkalotic and normal rats at high flow rates; (b) increasing perfusate tC02 concentration can suppress tCO2 entry; and (c) entry can occur in the absence of a gradient and this effect can be blocked by acetazolamide.
Introduction
In 1977, McKinney and Burg demonstrated that cortical collecting ducts taken from alkalotic rabbits secreted bicarbonate in vitro (1) . They also showed subsequently (2) that the rate of secretion could be enhanced by amiloride and inhibited by ac- etazolamide. Subsequently, others have confirmed the existence of collecting duct bicarbonate secretion in vitro and further, have shown that the transtubular chloride gradient can modulate this process (3) .
In the present studies, we undertook to demonstrate distal tubule bicarbonate secretion' in vivo by means of microperfusion experiments on alkalotic rats, normal rats, and rats subjected to amiloride and acetazolamide treatment. We recognize in these experiments that the distal tubule accessible to in vivo microperfusion is composed of a very heterogeneous epithelial cell population (4) . The first experiments, carried out in alkalotic rats, show that at high flow, net tCO2 accumulation can be demonstrated but is not modulated by reversal of the chloride gradient. In normal animals, high flow stimulates tCO2 accumu-lation even when perfusate concentration rises above that of plasma due to net addition of tCO2. Nevertheless, as the initial perfusate tCO2 concentration is increased, tCO2 accumulation is suppressed. Finally, we show that acetazolamide treatment can inhibit flow-stimulated tCO2 accumulation. Assuming there is no net intraluminal generation of bicarbonate, these results are consistent with a bicarbonate secretory effect.
Methods
These studies were performed on male Sprague Dawley rats, weighing -300 g, bred and raised in a climate-controlled facility at the University of Ottawa. The animals were allowed free access to water and food (rat chow 5012; Ralston Purina of Canada Ltd., Whitby, Ontario) until the time of experimentation. The rats were anesthetized with 100 mg/kg Inactin (BYK Gulden, Konstanz, Federal Republic of Germany) and prepared for micropuncture and distal microperfusion as previously described (4) . The data were derived from 239 distal tubule samples obtained from 92 rats. Of these, 96 were paired collections at two flow rates, 27
were early distal free-flow collections, and 20 were unpaired collections (see below). In all studies, the sequence of high and low flow perfusions was varied.
Experimental design. It is useful to give an overview of the rationale behind the sequential planning of our experiments. First, bicarbonate secretion was sought in alkalotic animals in view of previous reports (1, 2) . Initially, distal tubule perfusions were carried out in alkalotic animals under circumstances where the luminal chloride concentration exceeded that of plasma, presumably facilitating bicarbonate entry (3) . Having demonstrated bicarbonate accumulation, we next asked whether this could be attributed to the composition of the perfusate, the alkalotic state ofthe animals, or the flow rate. Therefore, we perfused distal tubules ofalkalotic animals at normal and high flow using a tCO2 concentration of 30 mM and Na, K, and Cl designed to simulate free-flow early distal fluid. These values were determined from the analysis of free-flow micropuncture samples. Having shown that JtCO2 was negative only at high flow in alkalotic rats, it next seemed appropriate to study normal animals. The perfusate tCO2 concentrations in three groups of normal animals of 10, 27, and 41 mM were chosen to establish: (a) a favorable plasma to lumen tCO2 gradient, (b) to minimize it, or (c) to reverse it. Because this led to the demonstration that high flow was associated with tCO2 accumulation in the presence ofa favorable gradient, we attempted to further examine this effect by use (4) . Normal rats. 37 normal rats were infused with donor plasma (0.5% of the body weight) followed by a sustaining infusion of isotonic saline at 1% of the body weight per hour. An additional five normal rats were dialyzed as described by Galla et al. (5) to provide a control for the dialyzed alkalotic animals. These rats were dialyzed against the control solution (5) and received plasmanate infusions (1% of the body weight) to sustain hematocrit at predialysis level. They were then infused with an isometric solution also as previously described (5) .
Acetazolamide-treated rats. 18 rats were subjected to systemic and intraluminal acetazolamide treatment. In all cases 10-3 M acetazolamide was added to the perfusate solution (see Table I ) and the animals received an intravenous loading dose of 20 mg/kg acetazolamide followed by a systemic infusion at the rate of 20 mg/kg per h in a 300 mM NaHCO3 solution. As Table II shows, this protocol resulted in the maintenance ofplasma total CO2 concentrations which were not different from control. In this fashion, the transtubular gradient for tCO2 was not altered with respect to control. Perfusion solutions. Table I lists the 10 perfusion solutions we used. As already indicated at the beginning ofMethods, solutions 1 and 2 were designed to reverse the chloride gradient while maintaining a perfusate tCO2 concentration similar to that previously used in distal tubule perfusion studies (4, 6) . Solution 3 was designed to simulate early distal fluid composition in alkalotic rats under free-flow conditions. To determine this composition, separate experiments were undertaken in eight dialyzed alkalotic rats whereby early distal free-flow collections were undertaken as previously described (7) . These samples were analyzed for [3H]inulin, Na, K, and total CO2 concentrations (see below). Thus, ac- Table I shows. Thus, the analyzed bicarbonate varied from 10 to 41 mM, while Na and K remained at -64 and 2 mM, respectively.
CO2 equilibration ofperfusion solutions. In our recent microperfusion study (4), we equilibrated perfusion solutions by the "indirect" method described by Cogan et al. (8) to attain a pCO2 of -65 mmHg. In this procedure, mineral oil is equilibrated with Hepes buffer solution consisting of 100 mM Hepes, 48 mM NaHCO3, and CO2 gas. Thereafter the perfusion solution is left in contact with this mineral oil. All mineral oil with which samples or perfusion solutions were in contact (micropuncture pipettes, perfusion pipettes, microcalorimetry sample tray, etc.) was exposed to the same CO2 equilibrated method. In the present studies, we have taken additional steps to establish an appropriate perfusate CO2 tension. Solutions 9 and 10 (see Table I ), were directly gassed using a 10% C02/90/ 02 mixture and thereafter, using macro acid-base methods (see below), the pCO2 was determined by direct measurement of pH and total CO2 (pCO2 = 72.0± 1.5 mmHg, n = 17) of the perfusate solution.
Using this method, we gained further confidence that a significant portion of the tCO2 accumulation we observed was not based upon insufficient tonometry of the perfusion solution. Indeed, using a gassed perfusion solution of 10 mM tCO2, 10 perfusions at high flow were carried out and these showed accumulation oftCO2 in 9 of 10 cases (JtCO2 =-31±8 pmol min-' mm-') and JtCO2 was significantly different from 0, P < 0.05. These 10 determinations are not shown in results and are distinct from the data shown in Figs. 2 and 3 and Table III . In addition, the experiments conducted to demonstrate bicarbonate entry without an initial gradient (solutions 9 and 10) also involve direct gassing. Thus, Fig. 3 (see Results) shows not only perfusion solutions carefully matched to plasma tCO2 concentration, but also direct tonometry to ensure appropriately high perfusate CO2 tensions. Ammonia entry studies. To evaluate the possibility that NH3 entered into the lumen and thereby generated bicarbonate, additional studies were carried out on six rats perfused at high flow with the most acidic perfusion solution (solution 6 containing 12 mM HCO3).
Analytical methods. Measurement oftritiated inulin concentrations, total CO2 by microcalorimetry, Na and K by graphite furnace atomic absorption, and calculation of fluxes have all been recently detailed (4).
Distal Tubule Bicarbonate Accumulation
In the present experiments, as before, the microperfusion pump was calibrated in vitro in the course of every experiment and quantitative collections were obtained so as to detect significant departures from nominal perfusion rates. The in vivo calculated perfusion rates were 7.1±0.4 nl/min (n = 92) and 23.7±0.5 nl/min (n 92). In the case of the 15 nl/min perfusion series, 13.6±0.2 nl/min (n = 20), was measured.
A similar small discrepancy between collected and nominal rates has been observed before (9) . Ammonia concentration was measured by the method of Cheema-Dhadli et al. which permitted the detection of 0.5 mM ammonium (10).
Statistical methods. Statistical methods consisted ofusing linear model procedures to assess the influence of the various contending variables. The response measure ofinterest i.e., the dependent variable, was JtCO2. Because the purpose of the analyses was to assess differences in JtCO2 across the experimental protocols, e.g., acetazolamide-treated versus normal rats, a basic analysis of variance approach was adopted. However, because there was also a need to control for simultaneous movements of H20, Na, and K, these parameters, centered about their means, were introduced as covariates into the model. Thus, comparisons between protocols consisted of comparing the JtCO2 means, adjusted for these confounding influences. This analysis strategy may be characterized as an analysis of covariance. F tests were performed to test statistical hypotheses in accordance with established statistical practice, and the resulting P values are reported throughout the text and in Table III .
The statistical procedures also took into account the fact that a pair of observations were recorded from each tubule, that is, one at 7 nl/min (normal flow) and the other at 24 nl/min (high flow). It would seem reasonable to suppose a priori that the same correlation structure existed between the two observations from the same tubule. This correlation structure was incorporated directly into the statistical model.
A separate analysis was performed to judge the relationship between JtCO2 and the concentration oftCO2 perfused. Here, a regression analysis was performed, with JtCO2 as the dependent variable and the mean tubular fluid total CO2 concentration as the independent variable. The analysis again adjusted for simultaneous movements of H20, Na, and K, and these were introduced as covariates into the model. In addition, since the relationship was expected to be different at the normal flow rate than at the high flow rate, a separate model was provided for each flow. Standard F tests were then performed to assess the significance of the predictor variables. Previous reports from this laboratory (4, 11) have also addressed these statistical issues.
Results Table II provides blood values on normal rats, alkalotic rats, and rats subject to acetazolamide treatment. In 27 nephrons (eight alkalotic rats) free-flow early distal samples were obtained and provided the following data: single nephron glomerular filtration rate, 31.8±1. 8 
Results from alkalotic rats
This first series of experiments was designed to detect tCO2 secretion in a setting where it could be expected to be present. Thus, we used alkalotic rats and instituted a high lumen to plasma chloride gradient (3). Table  I ). In addition, paired perfusions at 7 and 24 nl/min with solution 3 were also carried out on these animals. As Fig. 1 and Table  III show, in the 15-nl perfusion series, tCO2 secretion occurs and is significantly different from 0 but is not modulated by sulphate substitution for chloride (JtCO2 = -26±5 vs. -28±6 pmol* min' mm-l, P > 0.05).
To determine if tCO2 accumulation could occur at normal flow rates and with perfusion fluid composition similar to that found at the early distal tubule site of alkalotic rats, the paired perfusion studies were done. JtCO2 values for perfusion at 7 and 24 nl/min with solution 3 were 14±7 and -36±15 pmol * min-', mm-l, P < 0.01 (see also Table III ). In addition, multivariate statistical analyses (see Methods) also showed a relationship of JtCO2 to JK (P = 0.004) independent of the expected flow effect on K secretion. At 7 nl/min JK was -38±6 vs. -89±10 pmol * mind' mm-at 24 nl/min. (P < 0.01). Corresponding JNa values were 39±23 and -3±48 pmol. min-' mm-' at 7 and 24 nl/min, respectively.
Results from normal rats Because high flow was associated with tCO2 accumulation in alkalotic rats, we next considered whether normal rats would also show the same response. Further, in these animals we also wished to know if the lumen to plasma tCO2 gradient could modulate this effect.
Perfusion with 10 mM [tCO2]. Of nine animals studied in this group, five were subject to control dialysis (see Methods) and four were not dialyzed. The JtCO2 values given in Table III and Fig. 2 indicate a highly significant flow effect (P = 0.002); JtCO2 was -12±3 pmol min-'* mm-' at 7 nl/min and was -48±7 pmol * min' * mm-' at 24 nl/min. The initial perfusate tCO2 concentration of 10.3 rose to 17.6 mM in the normal flow Tables I and III. Distal Tubule Bicarbonate Accumulation from normal to high flow; (b) whether there is an overall effect ofperfusate tCO2 concentration on JtCO2 (i.e., in perfusing with 10, 27, 41 mM tCO2); and (c) whether there is a significant association between the tCO2 accumulation (-JtCO2) and mean tubular fluid tCO2 concentration that could reflect the presence of accumulation at high flow but not at normal flow.
To answer the first question, we have used the multivariate statistical approach to identify and account for confounding influences of other fluxes (JH20, JNa, and JK) on JtCO2 as well as the influence of changing perfusate composition. When this is done, a significant change in JtCO2 (P < 0.001) is still present in going from normal to high flow. This influence on JtCO2 of flow is also intuitively appreciated by observing the downward slope of the lines in the figures.
To answer whether JtCO2 is significantly associated with perfusate tCO2 concentration, again the simultaneous effects of JH20, JNa, and JK as well as flow are accounted for. When this is done, a highly significant association (P < 0.0001) emerges: i.e., changing perfusate tCO2 concentration from 10 to 41 mM (Figs. 2 and 5) is associated with a striking increase in JtCO2 values.
To address whether the tCO2 accumulation observed at high flow can be shown to be related to luminal tubular fluid tCO2 concentrations, regression analyses were done. These analyses allowed us to determine what the mean tubular fluid concentration should be when the JtCO2 becomes zero at normal and high flow. At normal flow rates, JtCO2 is predicted to be zero when the mean tubular fluid tCO2 concentration rises above 19 mM. At high flow, the mean tubular fluid tCO2 concentration is predicted to be 43 mM when JtCO2 is zero. In other words, high flow is associated with a limiting tCO2 concentration gradient that is more than twice that predicted to be associated with normal flow. This is consistent with the notion of a dissipative flow effect on tCO2 secretion as proposed in the Discussion.
Perfusion with 31 mM [tCO2] with and without acetazolamide. 10 tubules were perfused in seven rats with a tCO2 solution that had been directly gassed with CO2 (see Methods). The purpose of this series of experiments was to determine whether tCO2 entry could be elicited in the presence of careful matching of initial perfusion tCO2 concentration with plasma and whether acetazolamide could suppress tCO2 secretion. Fig.  3 and Table III show significant tCO2 accumulation occurred at high flow (P = 0.012). Associated with this net tCO2 accumulation, the initial perfusate tCO2 concentration of 31 mM increased in 8 of 10 instances to a mean value of 36.3±1.2 mM (see Fig. 3 and Table III) . That is, net accumulation continued while luminal tCO2 concentrations rose above plasma. Fig. 3 also shows the results of perfusion in the presence of acetazolamide (solution 10). JtCO2 at normal flow was 26±10 pmol* min-' * mm-' and was not significantly different from the high flow value of 19±8 pmol * min-* mm-' (P > 0.05). These positive values were significantly different from 0. Thus, acetazolamide not only blocked the flow effect but prevented net accumulation.
Other results from acetazolamide and amiloride experiments These experiments were undertaken to determine if acetazolamide could prevent tCO2 entry even when perfusate tCO2 concentration was much lower than plasma. Further, we also wished to know if in our experimental setting, amiloride could enhance tCO2 secretion as has been reported (2). Fig. 4 shows experiments Table III. carried out with 10 mM tCO2 perfusate (Fig. 4 A) , 10 mM tCO2 perfusate plus acetazolamide treatment (Fig. 4 B) , and 10 mM tCO2 perfusate plus amiloride (Fig. 4 C) . As Fig. 4 and Table  III show, a significant flow effect persists with amiloride addition to the perfusate. Amiloride did not enhance the rate of total CO2 accumulation. Acetazolamide treatment is not associated with a significant flow effect (P = 0.14) when adjusted for covariates if the model includes the 31 mM tCO2 plus acetazolamide perfusions (see above). However, when the 10 mM perfusions with acetazolamide are considered in isolation of the other acetazolamide experiments, a significant flow effect is present (P = 0.005). We believe the more appropriate analysis Tables I and III. is the former. Accordingly, acetazolamide abolishes the flow effect even when a gradient is present.
Discussion
Recently, it has been shown in vitro that collecting ducts can secrete bicarbonate after alkali feeding (1). Collecting duct bicarbonate movements have also been shown to be inhibited by acetazolamide in vitro (2) and a high lumen to bath Cl gradient has been noted to favour bicarbonate secretion (3) . In the present investigations, we demonstrate net bicarbonate accumulation in superficial distal tubules in vivo in a variety of microperfusion situations. This occurs in both alkalotic and normal rats, but only at high flow. It is modulated by the luminal bicarbonate concentration and can be inhibited by acetazolamide. Can these observations of distal tubule bicarbonate accumulation be taken as a demonstration ofbicarbonate secretion? As noted in Methods, the perfusion solutions were free of NH+, phosphate, nonbicarbonate buffers, and other constituents normally found in distal tubule fluid. Careful CO2 equilibration of perfusates prevented CO2 gas entry so that the tCO2 accumulation observed is not attributable to perfusate equilibration in situ by the peritubular gas tension. On the other hand, entry ofNH3 gas is theoretically possible and could therefore generate HCO3 by acting as a luminal proton acceptor. However, as noted in Results, separate studies showed that NHW? concentrations were insufficient to account for the tCO2 accumulation. Finally, it is conceivable that the absence of tubular fluid constituents normally found at the distal tubule site during free-flow could impede a unidirectional HCO3 (reabsorptive) flux that may be present. Were this so, a secretory component could be unmasked. Indeed, it is possible that differences between perfusion solutions and free-flow tubular fluid account for HCO3 reabsorption reported recently in free flow (12) but not in microperfusion studies (4, 6) .
Statistical methods. We have previously drawn attention, at some length to statistical approaches appropriate for micropuncture studies in which several variables are measured simultaneously (4, 11) . In the present study we have used approaches similar to those reported very recently (4) and, accordingly, we will not detail the arguments here. Briefly, we have undertaken multivariate statistical analyses which separate out effects on JtCO2 which may be caused by simultaneous movements of H20, Na, and K, in addition to flow effects and the different perfusion or inhibitor protocols employed. The results presented, therefore, are explicit with regard to assignment of, say, a flow effect on JtCO2. Thus, in a given experimental setting even though JtCO2 may be shown to be influenced by (or associated with) H20, Na, or K movements, a flow effect (which is also related to K movements) may nevertheless be present.
Alkalotic rats. We first examined alkalotic rats because it appeared reasonable, a priori, to demonstrate in vivo bicarbonate secretion during systemic metabolic alkalosis and, at the same 2. Table III reveals that at high flow, HCO3 accumulation rates for alkalotic rats (solution 3) are not different from similarly perfused control animals (solution 9), despite a more favourable plasma to lumen tCO2 gradient in the alkalotic group. It is possible that hypokalemia (see Table   II ) may have impeded HCO3 secretion by collecting duct-type epithelium in our alkalotic rats as has been suggested recently in potassium depleted rabbits ( 13). Fig. 2 and Table III. time, in the presence of high luminal chloride concentrations. Therefore, solution 1 was constituted so as to reverse the transtubular chloride gradient and to provide a bicarbonate concentration similar to that previously used in microperfusion studies in this and another laboratory (4, 6) . As already noted, net bicarbonate accumulation occurred and could not be suppressed when sulphate was substituted for chloride in the perfusion solution. In view of these results, we considered whether bicarbonate accumulation could also occur in alkalotic animals when the perfusate was identical to that occurring in vivo with respect to flow rate and composition. Based on the results of in vivo free-flow early distal collections, we constituted such a solution (Table I ) and perfused at both 7 and 24 nl/min, i.e., at normal and high flow. The failure ofbicarbonate accumulation to occur at normal flow indicated that systemic metabolic alkalosis in these animals was not a sufficient condition to elicit bicarbonate accumulation. However, at high flow, significant accumulation occurred,2 therefore requiring experiments on normal rats.
Normal rats. In normal rats distal tubules were perfused with four different total CO2 concentrations as well as with acetazolamide and amiloride. As already noted in Methods, the experiments involving 31 mM tCO2 were undertaken to ensure that initial perfusate tCO2 concentrations exactly matched those of plasma and that perfusate pCO2 was appropriate. The results of these perfusions in normal animals (Figs. 2-5 ) indicate unequivocally that perfusate tCO2 concentration and flow have significant effects on tCO2 accumulation. Thus, low flow and high perfusion tCO2 concentrations separately suppress tCO2 accumulation as seen in Fig. 5 . When the perfusate tCO2 concentration is 31 mM, i.e., when there is no initial plasma to lumen gradient, increasing flow from 7 to 24 nl/min elicits brisk secretion (Fig. 3) . Thus, it appears, that tCO2 accumulation can proceed against an electrochemical gradient insofar as the distal tubule is associated with a negative transtubular potential difference. As Fig. 3 shows, the perfusate concentration in association with net tCO2 accumulation rises to exceed the plasma by 6-8 mM. by acetazolamide and enhanced by amiloride (2) . This infers that amiloride inhibition could enhance bicarbonate secretion by impeding a bicarbonate reabsorptive counterflux and that acetazolamide would inhibit bicarbonate secretion by blocking the carbonic anhydrase (C.A.)-sensitive reaction: OH-+ CO2 C.A.
-> HCO5. In this view, hydroxyl ions are released into the cell cytoplasm, presumably by proton secretion at the antiluminal membrane. Fromter and associates have demonstrated in rat proximal tubules, that acetazolamide blocks bicarbonate exit from the cell by inhibiting the above reaction or some equivalent process (14, 15). Because our results show that acetazolamide treatment can suppress tCO2 accumulation, it is possible that distal tubule tCO2 secretion is also carbonic anhydrase dependent. That amiloride did not enhance tCO2 accumulation in our studies could imply that there was no proton secretory flux (which would reabsorb HCO3) in our HCO3-secreting distal tubules. This would be consistent with our previous microperfusion observations that distal tubules of normal rats do not reabsorb bicarbonate (4).
Flow effect. We now turn to a consideration ofhow increasing flow can elicit tCO2 accumulation even in the absence ofa transtubular tCO2 gradient. For us, the most accessible explanation is provided by the notion of a dissipative flow effect as offered by Wright (16) to explain entry of potassium in distal tubules at high flow. According to this view, the larger fluid volume presented to a secreting luminal epithelium will tend to reduce the concentration achieved by the secreted substance and thereby prevent the attainment ofa limiting concentration gradient. We recognize, of course, that unlike potassium, intracellular bicarbonate concentration is almost certainly very low (17) and its existence as an immutable ion in the cytoplasm is unclear. To evaluate this possibility, we have analyzed our data to reveal changes in JtCO2 as a function of mean luminal total CO2 concentrations (see Results). As already noted, high flow is associated with a limiting total CO2 concentration that is much higher than that predicted to be associated with normal flow.
What transport mechanism could underlie this association of higher limiting total CO2 concentrations at high flow versus normal flow? We know of no experimental basis for presuming that high flow or increased intratubular pressure could diminish active proton pumping. In fact, stretch has been recently reported to favour the insertion ofcytoplasmic vesicles in the total bladder thereby facilitating the establishment ofNa channels (18) . Ifthis analogy is extended to proton pumping, it would support the notion of enhanced rather than diminished hydrogen ion secretion at high flow. In fact, for the proximal tubule (19) Fig. 3 ) and that acetazolamide can inhibit this secretion, is in complete accord with the early report of McKinney and Burg (2), and with the current notion that bicarbonate secretion is active (20) . The present data imply that bicarbonate secretion may take place in vivo at high free-flow rates. It is of interest, therefore, to speculate under what circumstances this could occur in vivo and what its significance could be. It is well recognized that potassium secretion occurs at high flow (9) and recently it has been reported that net addition of NH' can also occur in distal tubules at high flow (22) . The simultaneous addition of bicarbonate under such circumstances would, ofcourse, tend to conserve Cl and also would offset the tendency to alkalosis that might be engendered by enhanced NH' secretion. Indeed, the recent suggestion of Garcia-Austt et al. (23) that cortical collecting tubule bicarbonate secretion stimulated by DOCA is a regulatory mechanism offsetting brisk medullary collecting duct proton secretion, is consistent with this notion: metabolic alkalosis associated with volume expansion and high tubular flow rates (i.e. NaHCO3 loading and DOCA administration) could be mitigated with high flow, signalling enhanced HCO3 excretion.
In summary, we have undertaken studies designed to examine bicarbonate secretion in distal tubules in vivo. We have shown under a wide variety of microperfusion situations that high flow is associated with tCO2 accumulation in the distal tubule lumen. The rate of tCO2 accumulation is modulated by altering the perfusate tCO2 concentration. However, accumulation still occurs when initial perfusate tCO2 concentration is equal to that of plasma, and indeed, persists in the face of rising luminal tCO2 concentrations. We propose that high flow favors tCO2 accumulation by impeding the attainment of a limiting concentration gradient. Results of acetazolamide inhibition suggest that tCO2 addition to the distal tubular lumen proceeds by a carbonic anhydrase-sensitive process which allows addition of tCO2 into the lumen against an electrochemical gradient. We have recognized that the absence of nonbicarbonate buffers and other constituents found normally in distal tubule fluid could have influenced our results: if a reabsorptive bicarbonate flux depends on such constituents, then their absence could unmask a secretory flux. Accepting this limitation, we conclude that these microperfusion results are consistent with flow-mediated bicarbonate secretion in rat distal tubules in vivo. 3 . Abbreviation used in this paper: DOCA, desoxycoricosterone acetate.
